HOME >> BIOLOGY >> NEWS
Jefferson scientists use gene therapy to restore function of damaged heart cells in lab

Researchers at Jefferson Medical College and Duke University have used gene therapy to help damaged heart cells regain strength and beat normally again in the laboratory. The work takes the scientists one step closer to eventual clinical trials in humans.

Walter Koch, Ph.D., director of the Center for Translational Medicine of the Department of Medicine at Jefferson Medical College of Thomas Jefferson University in Philadelphia, and his colleagues at Duke used a virus to carry a gene into the heart cells of individuals who had suffered from congestive heart failure. The gene introduced into these heart cells blocks the activity of an enzyme that is increased in failing human hearts and which contributes to the loss of the heart's contractile strength during the development of heart failure. When the activity of this enzyme is blocked by the gene therapy, the heart cells were able to contract at normal strength and their overall performance was improved.

Dr. Koch and his co-workers at Duke University Medical Center in Durham, N.C., report their findings April 6, 2004, in Circulation, a journal of the American Heart Association.

According to Dr. Koch, who is W.W. Smith Professor of Medicine at Jefferson Medical College of Thomas Jefferson University, researchers have known for some time that the beta-adrenergic receptor system fails to work properly in individuals with congestive heart failure. Such receptors "drive the heart both by rate and force of contraction," he says.

The researchers' target has been the beta-adrenergic kinase (ARK1), an enzyme that is elevated in human heart failure. One of its functions is to turn off beta-adrenergic receptors. "In heart failure, beta adrenergic receptor density is decreased, ARK is increased and both together cause dysfunctional beta receptor signaling," Dr. Koch says. "A failing heart then has little capacity to respond to exercise or stress because there are fewer receptors and the remaining rec
'"/>


5-Apr-2004


Page: 1 2

Related biology news :

1. Jefferson Lab detector technology aids development of cystic fibrosis therapy
2. Jefferson scientists find gene expression pattern may predict behavior of leukemia
3. Jefferson researchers develop microchip to track genetic signature of cancer and normal tissue
4. Jefferson researchers uncover biochemical clues to how cells migrate in embryos
5. Jefferson and Brigham and Womens researchers find blue light important for setting biological clock
6. Jefferson Lab experiment generates THz radiation 20,000 times brighter than anyone else
7. Jefferson scientists show neural stem cells can become dopamine-making brain cells in laboratory
8. Jefferson scientists show how collagen gene mutation leads to osteoarthritis
9. Jefferson scientists use gene repair technique to change albino mice hairs to black
10. Jefferson scientists show drug is effective against a Hepatitis C Virus model in the laboratory
11. Jefferson scientists propose mechanism to control the bodys red blood cell and platelet production

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/20/2019)... ... November 20, 2019 , ... BioInformatics Inc., part of Science and Medicine Group, ... the winners of the Life Science Industry Awards for the most innovative new products ... – Innovation: , Most Innovative New Product – Cell Biology, ...
(Date:11/19/2019)... ... 2019 , ... The inaugural Cell & Gene Therapy Day takes place February ... event will be chaired by Dr Aiman Shalabi, VP R&D, Cell and Gene Therapies ... are witnessing significant innovation in cell and gene therapies, and we are at a ...
(Date:11/14/2019)... (PRWEB) , ... November 13, 2019 , ... Personalized ... the first patients in an FDA approved clinical trial for stem cell treatment ... the formation of the company as a subsidiary of VetStem Biopharma. , In July ...
Breaking Biology News(10 mins):
(Date:12/6/2019)... ... December 06, 2019 , ... Southern ... for its latest CAPERE® Thrombectomy System for peripheral vascular, deep vein thrombosis ... benefits for first-in-line treatment for nonsurgical removal of soft emboli and thrombi ...
(Date:12/4/2019)... , ... December 03, 2019 , ... ... products and services, today announced a partnership with the Recombinant Antibody Network (RAN), ... Toronto, and UC San Francisco (UCSF) with a common goal to generate recombinant ...
(Date:12/4/2019)... ... December 03, 2019 , ... A new study released today in STEM CELLS ... reverse fibrosis (scar tissue) buildup – also improves the range of motion of the ... conducted on mice. , The tumor-destroying capabilities of radiation therapy can be a ...
(Date:12/4/2019)... , ... December 04, 2019 , ... The technology at ... a human hair, but its potential impact on the pharmaceutical industry could be massive. ... of biological and chemical engineering at South Dakota School of Mines & Technology ...
Breaking Biology Technology:
Cached News: